iPSC and mRNA for COVID-19 Research
Allele Biotech’s cGMP iPSCs Used as Packaging Factories for mRNA January 02, 2021 San Diego, CA January 2, 2021 (Updated from an earlier BusinessWire news announcement)– Allele Biotechnology and Pharmaceuticals, Inc. (Allele) has leveraged mRNA technology for over a decade to create cGMP-grade induced pluripotent stem cell (iPSC) lines for regenerative medicine and oncology applications.…